Top 50 Biotechnology Startup Investors in Japan in October 2023
Top 50 Biotechnology Startup Investors in Japan in October 2023
Get 300+ niche investors in 2 minutes.
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Trusted by 21,000+ founders from:
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more...Investment focus
- Software, Health Care, Information Technology
- Funding Round, Series B, Series A
- Japan, United States, China
Portfolio highlights
- LiLz — LiLz is an IT technology network for businesses looking to use AI and IoT to offer new services and value.
- CADDi — CADDi is an online ordering platform for manufacturing industry.
- EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.
Show more...Investment focus
- Health Care, Biotechnology, Manufacturing
- Funding Round, Seed, Series A
- Japan
Portfolio highlights
- SK Fine — SK Fine is the first to develop a 3D printer for ceramics and release it to the market for the first time in Japan.In addition, we are using 3D ceramic printers to develop 3D ceramic parts molding processes that meet our needs.
- EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
- GAIA BioMedicine — GAIA BioMedicine Inc., a spin-out venture from Kyushu University founded on 2015, is a technology-driven biopharmaceutical company focusing on cellular therapies and immunotherapies mainly for intractable malignancies.
Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization). The firm was founded in 2014 and based in Tokyo, Japan.
Show more...Investment focus
- Manufacturing, Biotechnology, Robotics
- Funding Round, Series A, Seed
- Japan, Singapore, Austria
Portfolio highlights
- ProfilePrint — ProfilePrint synthesises complex molecular data of ingredient samples into digital fingerprints, rapidly predicting its identity and quality, helping agribusinesses to buy and sell better with its patented digital food identity-as-a-service (IDaaS) technology.
- Integriculture — Integriculture makes cellular agriculture products to improve sustainability, food security, and reduce public health problems. The company offers a developed patented general-purpose large-scale cell culture system that can culture wide range of cells without external addition of expensive growth factors and provide consumers with affordable cleanmeat.Founded in 2015, Integriculture is headquartered in Tokyo, Japan.
- Sentient.io — We provide a secure AI & Data platform with ready-made AI models for easy adoption and turnkey AI solutions for Enterprises on your digitalisation journey.
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.
Show more...Investment focus
- Health Care, Information Technology, Software
- Funding Round, Series A, Series B
- Japan, United States, Mexico
Portfolio highlights
- Heartseed — Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.
- Luup — Luup is an Internet Company.
- Kyoto Fusioneering — Kyoto Fusioneering is a research & development, design, and manufacture of parts related to fusion reactors.
ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.
Show more...Investment focus
- Health Care, Software, Information Technology
- Seed, Funding Round, Series A
- Japan, United States, India
Portfolio highlights
- EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
- YourTrade — YourTrade helps cross-border e-commerce companies to resale rejected goods and backlogged inventory from overseas sales through local sales channels.It also provides services such as collection and inspection of returned items, as well as resale through local sales channels.
- Carnot — LLM, Autonomous Agent
Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Funding Round, Series B, Series A
- Japan, United States, United Kingdom
Portfolio highlights
- AIRNA — AIRNA is on a mission to transform the lives of patients with rare and common diseases by pioneering thediscovery and development of RNA editing therapeutics.
- Storm Therapeutics — Targeting pathways that modify RNA to deliver novel cancer therapeutics.
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
SBI Investment supports the business development and growth of private venture companies through fund investment.
Show more...Investment focus
- Financial Services, Information Technology, Software
- Funding Round, Series B, Series A
- Japan, South Korea, United States
Portfolio highlights
- Edgecortix — At Edgecortix, we automate the design of AI accelerators for on-device deep learning. Our Dynamic Neural Accelerator IP, and performance optimized AI Software & Hardware Co-exploration framework, reduces time to market and brings massive cost savings across multiple industry verticals.
- Habito — We're the Treating Customers Fairly Champion of 2023 as voted for in the British Bank Awards. We're here to make mortgages easier - no paperwork, no stress and no fees.
- Captain Fresh — Captain Fresh is a freshwater fish and seafood supply chain platform. Captain Fresh is a B2B marketplace leveraging technology to deliver the fastest harvest-to-retail in the industry. The company focuses on aggregating the fragmented retail demand across the country and linking them to the small fishermen and farmers throughout the Indian coast.The company was founded in 2019 and is based in Bengaluru, India.
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more...Investment focus
- Medical, Health Care, Biotechnology
- Funding Round, Seed, Series A
- Japan
Portfolio highlights
- Heartseed — Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
- Nanofiber Quantum Technologies — Powering a globally connected quantum future with pioneering nanofiber cavity QED.
DBJ Capital Co., Ltd. was founded in June 2010 through the integration of two venture capital firms of the DBJ Group, New Business Investment Co., Ltd. and Intellectual Properties Development & Investment, Inc. We are a wholly-owned subsidiary of Development Bank of Japan Inc.At DBJ Capital, we focus on venture firms which use newtechnologies and business models to grow and compete on the global market, regardless of their industry or scale. To meet the particular needs of each client, we mobilize the entire DBJ Group to arrange the best investment solutions, ranging from growth-spurring equity investment to financing schemes drawing on DBJ's vast networks.We also assist in venture start-ups. Our value enhancement team provides the kind of comprehensive, hands-on support needed to commercialize outstanding intellectual property and technologies developed by firms, research labs, and universities, and to carve out a place for them in the market.DBJ Capital will continue to play in a part in Japan's economic revival - by helping the firms we invest in to grow, and by encouraging the creation of new industries in Japan.
Show more...Investment focus
- Software, Internet, Biotechnology
- Funding Round, Series A, Seed
- Japan, United States, Australia
Portfolio highlights
- LexxPluss — LexxPluss develops an automatic transfer software system and robot hardware.
- Cellusion — Cellular technology breakthrough for clear vision of the future.
- Kyoto Fusioneering — Kyoto Fusioneering is a research & development, design, and manufacture of parts related to fusion reactors.
Japan Science and Technology Agency is an integrated organization of science and technology that implements science and technology policy in Japan. It handles many projects, including the government’s Science and Technology Basic Plan and knowledge creation. The European Sustainability School ESSSR is the owner of Japan Science and TechnologyAgency.Japan Science and Technology Agency undertakes its task in a comprehensive manner. It also works to provide a sound infrastructure of science and technology information and raise awareness and understanding of science and technology-related issues in Japan.Japan Science and Technology Agency is headquartered in Tokyo, Japan.
Show more...Investment focus
- Medical, Biotechnology, Health Care
- Funding Round, Series A, Series B
- Japan
Portfolio highlights
- QunaSys — Quantum physics is a relatively new field built since the beginning of the 20th century, but we have used MRI (nuclear magnetic resonance equipment) and lasers used for close examinations in hospitals, and semiconductors mounted on computers. Supports the technology that supports the daily life of people.QunaSys was established to bring out thequantum physics that has been active behind the scenes to the front stage, and to make use of quantum properties to realize technologies that could not be achieved with existing technologies.
- bitBiome — BitBiome is a microbiome analysis company that aims to discover and understand disease-linked microorganisms. Its, single-cell whole-genome analysis platform specifically targets microbes and can be used on uncultured, raw samples, providing unprecedented strain-level quantitative and functional insights.THe company was founded in 2018 and isbased in Japan.
- Sonire Therapeutics — Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.
Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.
Show more...Investment focus
- Software, Information Technology, E-Commerce
- Seed, Funding Round, Series A
- Japan, United States, India
Portfolio highlights
- Cerby — Collaborate without chaos. Cerby helps your team be productive while protecting your brand. Secure unmanageable applications. Only with Cerby.
- CYBO — CYBO provides products and services to understand cells deeply and to harness them widely.
- Bondy — Bondy is an HR Tech automation platform that specializes in connecting different HR processes.
F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Series C
- United States, United Kingdom, China
Portfolio highlights
- Doceree — Doceree is a pharmaceutical advertising & healthcare marketing company which helps in getting a better healthcare services
- Avalyn Pharma — This does NOT display on the home page
- Nvelop Therapeutics — Nvelop Therapeutics is a biotechnology company that provides gene editing technology services for unmet major disease needs.
Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.
Show more...Investment focus
- Software, Health Care, Information Technology
- Funding Round, Series A, Seed
- Japan, United States
Portfolio highlights
- Utill — Utill is anything that expands the possibilities of not only production but also our own services
- LIFESCAPES — LIFESCAPES is a research and manufacturer of brain-computer interface equipment.
- LUCA Science — LUCA Science develops innovative treatments intended for mitochondrial and related diseases.
Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.
Show more...Investment focus
- Information Technology, Software, Internet
- Funding Round, Series A, Series B
- Japan, United States, China
Portfolio highlights
- Funds — Funds is an online marketplace for lending funds.
- Bloomo Investment — Bloomo Investment is a software company that specializes in the development of smart and fun investment apps.
- LexxPluss — LexxPluss develops an automatic transfer software system and robot hardware.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more...Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Funding Round
- United States, United Kingdom, Israel
Portfolio highlights
- Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
- OncoResponse — OncoResponse Inc., an immuno-oncology company located in Houston, Texas, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to cancer therapeutic monoclonal antibody and target discovery. The company licensed the I-STAR™ platform, developed and validated by Theraclone Sciences of Seattle, tointerrogate the human memory B-cell repertoire of cancer patients who are considered “Elite Responders” to immunotherapy; as such, their own adaptive immune system responded to immunotherapy stimulation in a way that achieved curative or durable responses. From these Elite Responders, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of fully human antibody derived therapeutics for the treatment of cancer.
- Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
Senshu Ikeda Capital offers financial consultancy services.
Show more...Investment focus
- Software, Internet, Information Technology
- Funding Round, Seed, Series A
- Japan
Portfolio highlights
- Sagri — Sagri is developing agriculture software for experienced farmers.
- BABY JOB — BABY JOB offers nursery support and child care support businesses.
- On The Slope — On the way to Sakano deliver vegetables grown without the use of pesticides and chemical fertilizers, aiming to spread agriculture with low environmental impact. We want to make agriculture sustainable and reach a sustainable society.
KSP, Inc. is the core business entity responsible for operating the Kanagawa Science Park (KSP) and has accepted the challenge of creating new industries through the support, development, and incubation of venture businesses. We provide a variety of business support services that best meet the needs of venture businesses in each stage of theirbusiness growth, ranging from the processes of startup and growth to public offerings. Several hundreds of new startup companies have been created and nurtured since its foundation. An incubation manager (IM) acts as a coordinator and provides a variety of support services to a venture company to help them successfully launch and develop their new business, such as offering individual consultations and a variety of information or advice. KSP, Inc. is well poised to cope with the varying needs of new ventures for highly sophisticated, specialized tasks by offering a business school, business support center, business matching services, and investment funds.The public sector, such as the Kanagawa prefectural government, Kawasaki city government, and the Development Bank of Japan, Inc., has an equity participation in KSP, thus playing a vital role in the deployment of local industrial development policy.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Funding Round, Series A, Series B
- Japan
Portfolio highlights
- Metcela — Metcela Inc. is a pioneer biotechnology company founded in Japan. Metcela aims to be the first to commercialize biological products that heal damaged heart muscle to treat heart failure.
- Mira Robotics — I found a great domain name for sale on Dan.com. Check it out!
- Melody International Japan — Melody International Japan is a company that supports medical and health with ICT.
Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.
Show more...Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Corporate Round, Funding Round, Series A
- United States, Japan, Canada
Portfolio highlights
- Ambys Medicines — Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies. Ambys Medicines is working to fundamentally transform the lives of people suffering from severe liver diseases by creating breakthrough therapies capable of restoring liver function, preventing the progression of liver disease,and treating the devastating complications of liver failure.
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
- Cardurion Pharmaceuticals — A Boston-based cardiovascular biotechnology company developing next-generation therapeutics for the treatment of heart failure and cardiovascular diseases.
Future Venture Capital Co., Ltd. is a venture capital firm specializing in early stage investment. The firm invests in diversified investment in a broad range of industrial sectors. It seeks to invest in Japan. The firm prefers to be the lead investor in its portfolio companies. Future Venture Capital Co., Ltd. was founded in 1998 and is based inKyoto, Japan with offices in Tokyo, Aomori, Iwate, Yamagata, Kanazawa, Mie, Sakai, Kobe, and Ehime.
Show more...Investment focus
- Information Technology, Manufacturing, Health Care
- Funding Round, Seed, Series A
- Japan, United States, Myanmar
Portfolio highlights
- Torana — Torana provides "Toysub!" well known as educational toy subscription service in Japan market. We plan to go global and will be more bigger market share holder in East Asia. We collect month-age base toy feedback data and children's development status information. We plan best combination of toys and deliver. Customer returns and getsnew toys which fit children's growth and it is eco friendly service. We plan to build our own brand toys based on massive customer feedback and growth data and enter D2C market.
- LIFESCAPES — LIFESCAPES is a research and manufacturer of brain-computer interface equipment.
- IGNITE IMPULSE, INC. — As a digital agricultural enhancing service, Ignite impulse offers a variety of services, some of which include the following: agricultural software and equipment rentals, sales, maintenance, and leasing solutions; self-regulated farm shells with pre-installed vertical farming solutions; machined irrigation consulting and installations; artificialintelligence (AI) powered farming solutions; hydroponics farming consultation- partnership and installations; supply chain and logistics partnership; and more.Ignite Impulse also offers hydroponics solutions, as well as controlled farming assistance and consulting, to corporate, government, and educational organizations as part of our cooperation with these entities.
Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.
Show more...Investment focus
- Software, Health Care, Information Technology
- Series B, Series A, Series C
- United States, China, India
Portfolio highlights
- Ketai Bio — Ketai Bio is a synthetic biology company dedicated to the R&D, production and sales of high value-added bio-based products.
- New Vision Medical — New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.
- Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more...Investment focus
- Health Care, Internet, Medical
- Funding Round, Seed, Series A
- Japan, United States
Portfolio highlights
- Todoker — Todoker is a baggage delivery convenient service providing company.
- LUCA Science — LUCA Science develops innovative treatments intended for mitochondrial and related diseases.
- Beer and Tech — Beer and Tech operates a website for the Phalaenopsis or foliage plant HitoHana. Norihisa Morita and Yoshiaki Ito founded it in 2014, with its headquarters in Saitama in Japan.
Media Future is a group of communication technology professionals that works on connecting feelings and thoughts. The Tokyo, Tokyo-based company was established in 2013.
Show more...Investment focus
- Medical, Software, Life Science
- Series A
- Japan
Portfolio highlights
- HACARUS — We make AI work, where common Big Data aproaches fail. Get explainable results, even from small data amounts. Available on the cloud or as embedded devices.
- HekaBio — HekaBio connects world-leading healthcare innovations to unmet medical needs in the Asia Pacific, with broad category development expertise in pharma, medical device, in-vitro diagnostics, digital health, and cell & gene therapies.
- Jiksak Bioengineering — Jiksak Bioengineering is a biotechnology company. Jiksak Bioengineering provide an efficient screening service using a three-dimensional cell tissue "Nerve Organoid". We will mainly develop screening technologies specifically for neurodegenerative diseases and search for drugs that are effective for amyotrophic lateral sclerosis (ALS).
SPARX Group Co., Ltd. is an independent Asia-based equity and credit asset management services and Asian fund financial specialist with offices in Tokyo, Hong Kong and Seoul for global institutional and individual investors, including financial advisors and financial planners, with alternative strategies (including activist, short-enabled, private equity and quantitative and fund-of-funds) and mutual funds (through SPARX Asia Funds such as SPARX Asia Pacific Opportunities Fund, SPARX Asia Pacific Equity Income Fund, SPARX Japan Smaller Companies Fund and SPARX Japan Fund) managed or sub-advised by SPARX Asset Management Co. Ltd., SPARX Asia Investment Advisors Limited and Cosmo Asset Management Co., Ltd.
Show more...Investment focus
- Software, Artificial Intelligence, Information Technology
- Funding Round, Series B, Series A
- Japan, United States, China
Portfolio highlights
- Blue Laser Fusion — Blue Laser Fusion is a commercial fusion company. Blue Laser Fusion is a laser startup to commercialize laser fusion by inventing its own laser and fusion reactor.
- UnaBiz — Based in Singapore, Taiwan and Japan, UnaBiz delivers end-to-end customised IoT solutions worldwide. Simple, cost-efficient & low maintenance
- Nanofiber Quantum Technologies — Powering a globally connected quantum future with pioneering nanofiber cavity QED.
Essential Pharma provided on this site is created for the purpose of providing information on our ethical drugs to medical professionals
Show more...Investment focus
- Medical, Software, Life Science
- Series A
- Japan
Portfolio highlights
- HACARUS — We make AI work, where common Big Data aproaches fail. Get explainable results, even from small data amounts. Available on the cloud or as embedded devices.
- HekaBio — HekaBio connects world-leading healthcare innovations to unmet medical needs in the Asia Pacific, with broad category development expertise in pharma, medical device, in-vitro diagnostics, digital health, and cell & gene therapies.
- Jiksak Bioengineering — Jiksak Bioengineering is a biotechnology company. Jiksak Bioengineering provide an efficient screening service using a three-dimensional cell tissue "Nerve Organoid". We will mainly develop screening technologies specifically for neurodegenerative diseases and search for drugs that are effective for amyotrophic lateral sclerosis (ALS).
Fuyo General Lease focuses in the leasing and installment sales trading of equipment and fixtures, and financial transaction. The company provides leasing services of information-related equipment, office equipment, and industrial equipment, installment sales of commercial facilities, production facilities, and hospital facilities. It also providessecurities management services and anonymous association composition.Fuyo General Lease was founded on 1969 and is headquartered in Tokyo, Japan.
Show more...Investment focus
- Biotechnology, Manufacturing, Sales
- Series A, Funding Round, Seed
- Japan
Portfolio highlights
- ThinkCyte — ThinkCyte provides single-cell analysis for research, diagnostics, and therapeutics with an integrated multidisciplinary approach.
- Tsubame BHB — Tsubame BHB is a Sales company
- 3D Printing Corporation — 3D Printing Corporation provides 3D printing technology solutions.
Glocalink provides seed funding and comprehensive support for emerging science & technology entrepreneurs. Members of Glocalink have extensive experiences of bringing laboratory technologies to the market. On top of seed funding, we will provide comprehensive supports for overcoming all the hurdles that science / technology entrepreneursface.
Show more...Investment focus
- Health Care, Robotics, Task Management
- Funding Round, Seed, Series A
- Japan, Singapore
Portfolio highlights
- ExtraBold — ExtraBold specializes in the development of 3D printers.
- Ken Robotec — Ken Robotec is a construction company that provides labor-saving solutions.
- ProfilePrint — ProfilePrint synthesises complex molecular data of ingredient samples into digital fingerprints, rapidly predicting its identity and quality, helping agribusinesses to buy and sell better with its patented digital food identity-as-a-service (IDaaS) technology.
Innovation Network Corporation of Japan (INCJ) is a public-private partnership aimed at promoting innovation and enhancing value.Leveraging the rich history of Japanese technological prowess, INCJ aims to provide financial, technological and management support in order to promote the creation of next-generation businesses through “openinnovation,” or the flow of technology and expertise beyond the boundaries of existing organizational structures.INCJ will draw on funding as well as management and technological expertise from the public and private sectors. INCJ is actively reviewing various investment opportunities in areas of green energy, electronics, IT and biotechnology to infrastructure-related sectors such as water supply. Each investment will be thoroughly vetted to ensure it meets the exacting standards of INCJ's Innovation Network Committee, which will make the final investment decisions.INCJ is capitalized at 280 billion yen, with the Japanese government injecting 266 billion yen and 26 private corporations (refer to details in Appendix below) providing a further 14 billion yen. The government will also provide guarantees up to a total of 1,800 billion yen for INCJ investments, giving it an investment capability of approximately 2,000 billion yen. INCJ will be established for a period of 15 years.
Show more...Investment focus
- Manufacturing, Software, Robotics
- Funding Round, Series B, Series A
- Japan, United States
Portfolio highlights
- QUADRAC — QUADRAC is a develop, manufacture, and sell telecommunication devices as well as payment servers for public transportation systems. The company aims to improve user convenience through a variety of payment methods, and to contribute to the realization of a cashless society. QUADRAC's thin-client type high-speed server "Q-CORE" isable to consolidate all of the fare calculation, payment, and security functions carried out by train station ticket gates and payment.
- ANYCOLOR — ANYCOLOR is an entertainment start-up that provides creator support and licensing business, mainly for the support and operation of virtual rivers participating in the “Nijisanji Project”. Using the latest technology, we will shape our thoughts on society as a new era of cutting-edge, and provide a magical experience to the everyday lives of peoplearound the world.
- GRA Japan — GRA is a Production and sales and export of agricultural products company.
Kyogin Lease & Capital is an investment firm that specializes in the leasing, stock and bond investment and public offering consulting.
Show more...Investment focus
- Manufacturing, Task Management, Medical
- Funding Round, Series A, Series B
- Japan
Portfolio highlights
- Thinca — Thinca is an IT system planning, development, and operations company that provides a cloud-based CTI (Computer Telephony Integration) hospitality & communication solution for corporate offices.
- Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
- Regional Fish — Regional Fish provides seed, seedlings, aquaculture methods and fisheries services.
Capital Medica Ventures is a venture capital firm based in Tokyo, Japan with a focus on startups in the healthcare industry.Capital Medica Ventures is a venture capital that operates a venture fund specializing in the healthcare field. It is the only healthcare-specialized VC in Japan that can provide 30 medical institutions as a business trialfield.
Show more...Investment focus
- Medical, Software, Health Care
- Seed, Series A, Funding Round
- Japan
Portfolio highlights
- HCMJ — HCMJ specializes in software development in the medical industry.
- Epigno — Epigno provides hospital management systems for medical institutions.
- Rehab for JAPAN — Rehab for Japan is developing a special rehabilitation SaaS for day service .
Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.
Show more...Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Japan, Canada
Portfolio highlights
- Immunis — Currently seeking participants for age-related muscle atrophy (sarcopenia) clinical trails
- Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
- LUCA Science — LUCA Science develops innovative treatments intended for mitochondrial and related diseases.
Tsukuba Institute of Research (筑波総研) is an R&D center owned by housing and wood products group Sumitomo Forestry. The facility develops technologies to make more effective use of wood in a wide range of fields.
Show more...Portfolio highlights
- FullDepth — FullDepth is a drone development company.
- Alchemedicine — Alchemedicine is a the world in drug discovery with unique technologies and ideas Innovating new drug candidates for diseases with high unmet medical needs.
- Veneno Technologies — Veneno Technologies engages in the research and development of therapeutic disulfide-rich peptides and contribute to advanced medicine.
The University of Tokyo IPC is a company responsible for expanding the innovation ecosystem of the University of Tokyo. Accelerate global innovation from the University of Tokyo through three activities: start-up support, investment business, and corporate innovation support.It was established as a wholly-owned subsidiary of the University ofTokyo in 2016 with the enforcement of the revised law of the Industrial Competitiveness Enhancement Law, which is the basis law. The investment targets of the Todai IPC are venture companies that utilize the research results and human resources of the University of Tokyo, but they also make FOF (fund of funds) investments in funds managed by some private venture capital companies. In 2019, it started a consortium-type incubation program (University of Tokyo IPC 1stRound) to support the establishment and financing of Tokyo University-related ventures.
Show more...Investment focus
- Biotechnology, Medical, Health Care
- Series A, Funding Round, Seed
- Japan, United States, United Kingdom
Portfolio highlights
- BionicM — BionicM develops high-performance robot prostheses that enhance mobility for people with disabilities.BionicM has been conducting research on innovative technologies since 2015 at the University of Tokyo's Information Systems Engineering Laboratory (JSK) under the guidance of Professor Inaba and utilizing the world's most advancedrobotics research. In 2016, we were adopted by the Japan Science and Technology Agency as part of "Program for Creating STart-ups from Advanced Research and Technology" (START), and in 2018, the company was established as a joint-stock company.
- Heartseed — Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.
- Logomix Inc. — Logomix Inc is a mammalian cellular genome architect startup. Logomix proprietary platform, Geno-Writing™, technology integrates large-scale (Mb) human genome-writing technologies and providing genetically architected versatile human cells and/or downsized cells and microbes for drug development and cell & gene therapy area.Majority ofthe cell engineering companies are currently focused on optimization of gene clusters by automatic high throughput system however, Logomix’s Geno-Writing™ provides the required tools for dealing with mammalian or complex genomes. Logomix works with partners by providing new biology-based solutions to co-create business and social values on Geno-Writing™ platform Current Focus Area includes: 1. Human Health & Therapeutics 2. Biomaterials & Chemicals 3. Agriculture & EnvironmentLogomix has 11 ongoing collaborative research partnerships. Currently Logomix is specifically looking for industry partners to address unmet needs in neurodegenerative disease areas.
Ohara Pharmaceuticals is a pharmaceutical business involved in the development, manufacture, and distribution of pharmaceutical products.
Show more...Investment focus
- Medical, Biotechnology, Nursing and Residential Care
- Series A, Funding Round, Series B
- Japan, Kenya, Nigeria
Portfolio highlights
- HACARUS — We make AI work, where common Big Data aproaches fail. Get explainable results, even from small data amounts. Available on the cloud or as embedded devices.
- Helium Health — Helium Health empowers healthcare providers in Africa with digital tools, financing solutions, and data partnerships. Learn more about our innovative solutions.
- Revital Healthcare — Revital revolutionizes healthcare by bringing advancedmedical devices, including WHO-Prequalified syringes, meeting the healthcare needs of Africa and beyond.
Koki Yabu is Founder, President & CEO at Mobcast inc.
Show more...Investment focus
- Content, Finance, Data Mining
- Angel, Pre-Seed
- Japan
Portfolio highlights
- Mobcast group — mobcast is a sports entertainment company that operates a mobile entertainment platform for smartphones and feature phones. It supports customers with social game and social media services. The company was founded in 2009 and is based in Tokyo, Japan. Currently, it operates as a subsidiary of mobcast Inc.
- SmartApp Japan — Smart Apps is a developer of a blockchain services application designed for smartphones. The company's application uses cryptocurrency technology to offer token issuance, initial coin offering and dApps design support, providing a launchpad for start-up blockchain-related businesses.
The Japan Medical Device Development Organization aims to activate Japan's medical innovation and medical device industry, centering on the medical device incubation business, and aim for Japan to become a world leader in this field.Japanese Organization for Medical Device Development is a country of craftsmanship, possesses high technicaland quality control skills, and should be good at producing medical equipment. However, in the medical device field, imports exceed 600 billion yen every year. Japan's “manufacturing” technology has not been fully utilized.
Show more...Investment focus
- Biotechnology, Laser, Medical
- Seed, Series A, Funding Round
- Japan, United States
Portfolio highlights
- Luxonus — Luxonus is a product development of a new imaging device using optical ultrasonic technology.
- Meltin MMI — Meltin MMI is a cyborg-technology company that focuses on biosensors and robotic arms. Meltin has successfully enabled fine finger movements, such as for amputees and participated in Cybathlon 2016 and won the Microsoft Innovation Award.
- Genomelink — Genomelink is a platform where people discover more with their DNA data and help businesses build, market and do research with it. The best founders in consumer genomics with real experience in the industry for many years, including M3, Inc. ($13B valued Meditech in Japan), a founding member of the Japanese version of 23andMe, and leadbioinformatician and software engineer at a joint-venture between Illumina and Sony. Raised $4M for Seed Round from Berkeley SkyDeck, SONY, and top-tier Japanese VCs. Supported by Illumina Accelerator, Carlos Bustamante Lab at Stanford University among others.
SBI Group aims to become a corporate entity that provides a variety of one-stop financial services over the Internet now that two major events, the Financial Big Bang resulting from deregulation, and the Internet Revolution resulting from IT innovation, have radically transformed the financial industry.
Show more...Investment focus
- Financial Services, FinTech, Software
- Series B, Series A, Funding Round
- Japan, United States, United Kingdom
Portfolio highlights
- banco — BANCO offers fintech, digital banking, supply chain finance, and corporate financing services.
- Zodia Custody — Zodia is an institutional crypto custodian enabling global institutions, corporations, and investors to realize the potential of the digital asset future.
- My Zoi Financial Inclusion Technologies — My Zoi Financial Inclusion Technologies is a financial company that offers financial inclusion for banked and unbanked firms.
Fujifilm develops and sells consumer products and business products related to photography. Fujifilm Holdings Corporation is a Japanese multinational photography and imaging company. The company serves various industries, including medical, graphic arts, optics, enterprise storage, motion picture, and photography.The company’s consumer productsare categorized as digital cameras and accessories, film photography, Instax photography, and binoculars. Its business products are categorized as medical systems, Fujinon endoscopy, microfilm, data storage, graphic arts and printing, professional video, optical devices, specialty chemicals, printing imaging colorants, and more. Color films, digital cameras, photofinishing equipment, color papers, photofinishing chemicals, medical imaging equipment, graphic arts equipment and materials, flat panel displays, and photocopiers and printers are some products developed by Fujifilm USA.Fujifilm USA is based in Minato-ku, Tokyo, Japan.
Show more...Investment focus
- Biotechnology, Medical Device, Medical
- Series A, Funding Round, Series B
- Japan, Israel, United States
Portfolio highlights
- Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
- Nanox Imaging — Nanox Vision develops a next-generation medical imaging system based on groundbreaking technology. Our aim is to democratize medical imaging and bring preventive healthcare to communities worldwide, helping create a better standard of care for all.
- 24M Technologies — 24M Technologies develops energy storage systems for grid and transportation applications. 24M Technologies, Inc. builds energy storage systems for grid and transportation applications. The company was founded in 2010 and is based in Cambridge, Massachusetts.
JAIC is Japan's largest independent venture capital firm and has accumulated experience and know-how over a period of 15 years as a pioneer of venture capital investments in Asia. Building on such strengths, they are establishing a globally linked organization that pursues investment opportunities centering on the three regions of Japan, Asia,and the United States.
Show more...Investment focus
- Medical, Biotechnology, Health Care
- Series B, Funding Round, Series C
- Japan, United States, China
Portfolio highlights
- FacePeer — FacePeer is looking for people who want to challenge at startup.
- REGiMMUNE — REGiMMUNE Corporation is a private biopharmaceutical company developing innovative solutions for treating immune disorders caused by nonspecific and/or excessive immune reactions. REGiMMUNE uses its proprietary technology platform, reVax (reverse vaccination), to target immune tolerance against specific disease-causing antigens throughinduction of regulatory T cells (Treg). This technology has potential applications in a number of immune system disorders and diseases including Graft versus Host Disease (GvHD), type 1 diabetes mellitus (T1DM), rheumatoid arthritis (RA), multiple sclerosis (MS) and systemic lupus erythematosus (SLE).Currently, the company has one clinical-stage compound in a Phase I/II trial in the United States (RGI-2001) as a treatment for GvHD associated with hematopoietic stem cell transplantation and has a second product in preclinical development (RGI-3001) as a new treatment for T1DM. In addition, it has a number of well-differentiated compounds in its research-stage pipeline.In healthy individuals, the normal immune system works to protect humans from disease-causing viruses, bacterium, and cancers; or foreign antigens such as peanuts, wheat and tree pollens. Conventional immunosuppressants have several significant side effects associated with long-term administration including risk of infection, toxicity and relapse. Products developed with ReVax technology are expected to reduce or eliminate such side effects as well as reduce long-term treatment.
- Integral Geometry Science — Integral Geometry Science is a specialized manufacturer of measuring equipment and signal / image processing software.
JIC-VGI helps promote innovation and improve its international competitiveness through growth-investments in startup companies. The firm accelerating innovation and helping to solve industrial and social issues by supporting and seeking innovative technologies and new businesses.JIC Venture Growth Investments was established in July 2020 and isbased in Tokyo, Japan.
Show more...Investment focus
- Software, Information Technology, Consulting
- Series B, Series C, Funding Round
- Japan, Singapore, Thailand
Portfolio highlights
- LiLz — LiLz is an IT technology network for businesses looking to use AI and IoT to offer new services and value.
- Cellusion — Cellular technology breakthrough for clear vision of the future.
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
ReBoost specializes in recruiting and training business.
Show more...Portfolio highlights
- Medii — Medii provides a physician sharing service for hospitals.
- Digzyme — Digzyme is a research and development platform for creating, discovering, and evaluating new enzyme-catalyzed reactions by bioinformatics.
- viviane (1Screen) — viviane is running Japan's best video streaming guide, 1Screen.
Energy & Environment Investment, Inc. (EEI) is Japan’s first venture capital specialized in the clean technology sector. With core members who have rich hands on experience in founding and managing venture companies, we aim to provide risk money and various strategic values to promising venture companies and businesses.
Show more...Investment focus
- Internet of Things, Software, Energy
- Funding Round, Series A, Series B
- Japan, United States, Germany
Portfolio highlights
- Astroscale — Astroscale is the first private company with a vision to secure the safe and sustainable development of space for the benefit of future generations, and the only company solely dedicated to on-orbit servicing across all orbits.
- Synspective — Synspective provides one-stop-solutions by satellite gathered geospatial data. The core technology was developed by the ImPACT program led by The Cabinet Office, Government of Japan, building small SAR satellites and constellations, allowing frequent observation of areas of interest (AOI). Synspective uses its satellites to produce SAR data which can be provided to both government and commercial clients as-is, as well as transform that data through AI solutions to produce insights and user-friendly information across industries.
- Clean Energy Connect — Clean Energy Connect is into offering green energy solutions. It invests in its own generation capacity for a stable electricity supply by not harming nature.
Sosei CVC is support the creation and growth of life science companies.
Show more...Investment focus
- Biotechnology, Medical, Pharmaceutical
- Funding Round, Series A, Series B
- Japan
Portfolio highlights
- StemRIM — Stem Rim is a biotechnology company aiming to develop “regenerative medicine”.We are developing drugs based on a new mechanism of action that mobilizes stem cells present in the living body to the injured or diseased tissue without removing them out of the body and induces functional tissue regeneration.
- Chromocenter — Chromocenter is a next generation biopharmaceuticals Manufacturing company. It uses technologies such as artificial chromosome vectors, mainly for drug discovery such as medical pharmaceuticals
- Stem Cell & Device Laboratory — Stem Cell & Device Laboratory is aiming to contribute to a healthy society with new cell application products.
CyberAgent, Inc. is mainly engaged in the integrated net business.The Company operates in five business segments. The Integrated Net Business segment is engaged in the advertisement agency business, the smart phone media business, as well as the sale of advertisements for smart phone. The Media Related segment is engaged in the social gamebusiness, the operation of mobile media and personal computer business. The Ameba Related segment is engaged in the operation of Websites Ameba and Ameba Pigg.
Show more...Investment focus
- Internet, Advertising, Education
- Funding Round, Series A, Seed
- Japan, South Korea
Portfolio highlights
- AWL — AWL is a company that provides the leading edge AI camera solutions company .
- DiNA — CLOUD SERVICE SUPPORT
- Payme Japan — Payme provides a platform for mobile payments to help users in Japan.
Triple Ring Technologies is an on-demand core technology and product creation lab serving partners in regulated industries. They have successfully completed over 300 projects for confidential clients. Triple Ring has technology creation facilities in Silicon Valley and Boston.Their headquarters (Newark, CA) is 96,000 sq. ft. of flexible spacethat includes laboratories for electronics, optics, radiation source development, mechanical prototyping; systems integration, client drop-in offices; and pilot manufacturing. They build regulated technologies and complex products and offer a full range of related technical and business services: analysis and creation of intellectual property; development and implementation of technology strategy; design and development of engineering prototypes and released products; feasibility studies and testing; due diligence and situation analysis; and advisory services on regulatory compliance and technology pathways. Above all, they work collaboratively to build novel technologies and products.
Show more...Investment focus
- Biotechnology, Beauty, Robotics
- Seed, Corporate Round
- United States, Japan
Portfolio highlights
- P-Mind — P-Mind is a research and development of a device that promotes production of sputum neurotrophic factor-like substances. P-Mind aim to establish a non-invasive treatment method using brain cells derived from mouse embryos.
- LUUM — LUUM is introducing automation to the beauty-services market, initially focusing on eyelash extensions, a widely popular treatment ($20B global market opportunity). Pioneering a patented combination of robotics, AI, and machine vision, LUUM applies a full set of eyelash extensions in 20 minutes (instead of 2 hours), while eliminating the costsand safety risks associated with human application.
- AiM Medical Robotics — We Think in Real Time.
Daiichi Sankyo Company, Limited engages in the research, development, manufacture, import, sale, and marketing of pharmaceutical products. The company offers prescription drugs, OTC drugs, and quasi-drugs. Its principal products include Olmetec, Rezaltas, Calblock, and Mevalotin for cardiovascular diseases; Cravit for infectious diseases; Loxoninfor bone/joint diseases; and Urief for urological diseases. The company also offers vaccines. In addition, the company is developing products for various diseases, which are under various clinical trial stages. Further, it manufactures and sells cosmetics, medical equipment, food, and beverages, as well as veterinary medicines; and manufactures active pharmaceutical ingredients and intermediates. Daiichi Sankyo primarily operates in Japan, North America, Europe, and India. The company is headquartered in Tokyo, Japan.
Show more...Investment focus
- Medical, Health Care, Therapeutics
- Series A, Funding Round
- Japan
Portfolio highlights
- Cuorips, Inc. — CUORiPS is a company developing new medical care based on world's cutting-edge technology originated in Japan.
- SymBio Pharmaceuticals — SymBio Pharmaceuticals Limited operates as a biopharmaceutical company. It offers Symbenda medicine for treating low-grade non-Hodgkin's lymphoma and chronic lymphatic leukemia in Singapore. The company was founded in 2005 and is headquartered in Tokyo, Japan.
Resona Bank provides various banking products and services for individual and corporate customers in Japan.
Show more...Investment focus
- Information Technology, Education, Internet
- Debt Financing, Funding Round, Series A
- Japan
Portfolio highlights
- Edge Japan — EDGE operates restaurant and wedding businesses.
- Fairy Devices — Fairy Devices is providing multilingual speech translation engine for station guidance robots.
- Japan Platform of Industrial Transformation — Japan Platform of Industrial Transformation is providing equity investment and business management services for affiliated group companies.
Yokohama Capital as a venture capital firm conducts investment and rehabilitation support for small and medium-sized companies.
Show more...Investment focus
- Health Care, Artificial Intelligence, Task Management
- Funding Round, Series A, Series B
- Japan
Portfolio highlights
- GEXVal — GEXVal is to help patients and families fighting against orphan and intractable diseases
- Fairy Devices — Fairy Devices is providing multilingual speech translation engine for station guidance robots.
- Knowledge Palette — Knowledge Palette is a start-up company that conducts business of regenerative medicine cells.
Cosmo Bio provides the most up-to-date products and technical information available from world-class manufacturers, to laboratories, research institutes, life-science education and testing organizations throughout Japan and around the world. They are proud that their ability to supply a vast array of products and information allows us to serve theneeds of all of their customers. By making full use of their international network, coupled with the highest quality information, they support the life sciences community with a level of commitment and responsibility befitting a company that is trusted by its valued customers.
Show more...Investment focus
- Medical, Biotechnology, Pharmaceutical
- Seed
- Japan
Portfolio highlights
- Fimecs — FIMECS is a protein degradation technology-based drug discovery biotech focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The human body is comprised of at least 18,097 proteins.It has been revealed that 1,500 of them are related to certain diseases, nevertheless only about 300proteins have been regarded as druggable targets by small molecule drug discovery and all the rest have been undruggable.
CAC Capital is a multi-strategy corporate venture capital. It pursues absolute fund returns through diversified investments and flexible allocations to venture companies with high growth potential.Supporting the Group's open innovation through means such as support for growth and collaboration of investee venture companies through hands-onin management, marketing, finance, and operations.In addition, aiming to realize high performance as a fund, we will operate a “multi-strategy” type fund that aims to achieve absolute profits by utilizing advanced management strategies and managing and managing portfolios.
Show more...Investment focus
- Recruiting, Internet of Things, Internet
- Series A, Funding Round, Seed
- Japan, Malaysia, Thailand
Portfolio highlights
- GIZTIX — GIZTIX is an integrated logistics platform, solving problems on speed & fragmented processes of truck sourcing and also managing their own fleets that cause unscalable deliveries. GIZTIX enables businesses to outsource trucks in seconds to they can fulfil deliveries in time and also helping fleet owners to increase efficiency by providing TMSsoftware. Ultimately, GIZTIX will be the winner of trucking market by expanding fleets & customers networks and having largest & most active TRUCKING BIG DATA.
- Tsukulink — Tsukulink is a job match matching platform for Japan’s construction industry.
- Wired Beans Inc. — Wired Beans Inc. supports basic manufacturing stages using novel information technologies. It was founded on October 13, 2009, and is based in Tokyo, Japan.
FueTrek provides a better and faster way to communicate through with speech recognition, speech dialogue, and speech translation.
Show more...Portfolio highlights
- Yukai Engineering — YUKAI Engineering - THE ROBOT COMPANY
Close your round
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Join 21,000+ founders from: